Gene: UBE2O
Official Full Name: ubiquitin conjugating enzyme E2 Oprovided by HGNC
Gene Summary: Enables ubiquitin conjugating enzyme activity and ubiquitin protein ligase activity. Involved in positive regulation of BMP signaling pathway; protein ubiquitination; and retrograde transport, endosome to Golgi. Located in cytoplasm and nuclear body. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12870 | UBE2O Knockout cell line (HeLa) | Human | UBE2O | 1:3~1:6 | Negative | Online Inquiry |
KO12871 | UBE2O Knockout cell line (HCT 116) | Human | UBE2O | 1:2~1:4 | Negative | Online Inquiry |
KO12872 | UBE2O Knockout cell line (HEK293) | Human | UBE2O | 1:3~1:6 | Negative | Online Inquiry |
KO12873 | UBE2O Knockout cell line (A549) | Human | UBE2O | 1:3~1:4 | Negative | Online Inquiry |
UBE2O Gene Knockout Cell Lines are genetically engineered cellular models that have been specifically designed to lack the UBE2O gene, a crucial component in the ubiquitin-proteasome system involved in protein degradation and cellular regulation. These knockout cell lines enable researchers to investigate the biological pathways governed by UBE2O, shedding light on its role in cellular processes such as apoptosis, DNA repair, and cell cycle progression.
The mechanism of action in UBE2O gene knockout cell lines revolves around the removal of UBE2O's expression, resulting in an altered proteomic landscape within the cells. This allows for the study of compensatory pathways and the involvement of other E2 ubiquitin-conjugating enzymes that may be activated in the absence of UBE2O. Such insights are pivotal in understanding various diseases, particularly cancer, where aberrations in protein degradation mechanisms are often observed.
Scientifically, these cell lines stand at the forefront of research applications, facilitating drug discovery, and the development of targeted therapies. They are particularly beneficial for investigators studying pathways related to ubiquitination and protein turnover, which are integral to many physiological and pathological processes. In clinical settings, UBE2O knockout models can assist in identifying novel therapeutic targets and understanding drug resistance mechanisms.
Compared to traditional cell lines, UBE2O knockout cell lines offer significant advantages, including precise genetic modifications, reproducibility, and the ability to study the specific loss of function of the UBE2O protein without confounding factors. These models provide a more accurate representation of human disease states, which is critical for translational research.
For researchers and clinicians alike, UBE2O Gene Knockout Cell Lines present a valuable tool in the quest to unravel complex biological interactions and develop innovative therapies. Our company, committed to advancing biomedical research, offers these superior cell lines alongside unparalleled technical support and expertise, ensuring that users maximize their research outcomes with the best available models.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.